Pharmaceutical Executive - Pharmaceutical news and analysis. Pharma management, sales, marketing & finance

ADVERTISEMENT

Previous Story Play / Pause Next Story
New & Noteworthy
Dealmaking: Staying Ahead of the Curve
Amid the continued surge in M&A activity, Michael Swanick asks, what are the crucial considerations pharma executives should weigh before sitting down at the deals table?
Crowdfunding: The Open-Source Option Against Capital Crunch
Is crowdfunding an attractive alternative to finance pharma and biotech start-ups? Seth R. Ogden and M. Andrew Holtman report.
TAG Touts Progress in Global Access to TB Drugs
TB advocacy campaigner Treatment Action Group (TAG) has reached a milestone in improving access to TB treatments. Casey McDonald reports.

Latest Pharm Exec Videos

Events
Medicaid and Government Pricing Congress
June 3, 2015 - June 5, 2015
Lake Buena Vista, FL USA

13th Annual Product Complaints Congress for Life Sciences
June 23, 2015 - June 25, 2015
Washington, DC USA

PAAS 2015 – Patient Adherence and Access Summit
June 23, 2015 - June 24, 2015
Philadelphia, PA USA

Contracts, Chargebacks and Rebates Congress
June 24, 2015 - June 25, 2015
Philadelphia, PA USA

Speed to Therapy
August 11, 2015 - August 12, 2015
Philadelphia, PA USA

The Baltic States: A Location for Your Next Clinical Trial
New CDER Super Office to Promote Drug Quality
Pulling Back the Curtains on Obamacare Rx Usage
Cancer Medicines: Setbacks and Stepping Stones
Unlocking the True Value of Big Data: A Pharm Exec Global Digest Special
Preparing for Reentry: A Physicians Story
From the Editor William LooneyYouthquake: How the Millennials are Shaping US Healthcare
Europe ReflectorEruptions on the European Drug-Pricing Horizon
Training Stan BernardGain Competitive Advantage: Think Like a Navy SEAL
Biosimilars Jill WechslerGaps in Global Standards Threaten Biosimilar Development
 More
Survey
Which of these concerns you the most with regard to your firm's growth prospects?
Slow or negative growth in developed economies
Slowdown in high-growth markets
Slow or negative growth in developed economies
63%
Slowdown in high-growth markets
38%
View Results
PHARM EXEC GLOBAL DIGEST
Pharmaceutical Executive Digest EuropeTo read the latest issue of Pharm Exec Global Digest
Click here. Click here to receive the Digest into your inbox every month.
Click here